Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alcon Inc (GB:0A0D)
LSE:0A0D
Holding GB:0A0D?
Track your performance easily
0A0D Stock Chart & Stats
Day’s RangeCHF0 - CHF0
52-Week RangeCHF61.36 - CHF85.56
Previous CloseCHF82.19
Volume10.14K
Average Volume (3M)31.71K
Market Cap
CHF41.00B
Enterprise ValueCHF44.45B
Total Cash (Recent Filing)$1.10B
Total Debt (Recent Filing)$5.15B
Price to Earnings (P/E)41.2
Beta0.51
Next Earnings
Nov 12, 2024EPS Estimate
CHF0.63Last Dividend Ex-Date
May 14, 2024Dividend Yield0.28%
Share Statistics
EPS (TTM)1.98
Shares Outstanding499,700,000
10 Day Avg. Volume28,589
30 Day Avg. Volume31,710
Standard Deviation0.07
R-Squared0.10
Alpha0.00663
Financial Highlights & Ratios
Price to Book (P/B)2.07
Price to Sales (P/S)5.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.20
Enterprise Value/Gross Profit8.47
Enterprise Value/Ebitda47.14
Forecast
1Y Price Target
CHF87.93Price Target Upside6.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
Alcon News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceEPS of $0.74 beat consensus $0.73 and grew 15% cc.
Market PositionAlcon is a leader in the $30B+ ophthalmic device market, holding a #1/#2 position across most surgical and vision care categories in which it competes.
Product LaunchUNITY Vitreoretinal Cataract System secured FDA clearance and is expected to bring substantial revenue.
Bears Say
Earnings OutlookAlcon points towards the lower-end of the sales, EBIT, and EPS guidance range for FY24.
Financial PerformanceSales came in approximately 2% below consensus in 2Q24, with all divisions missing estimates except Implantables.
ProfitabilityMargins were affected by a supplier-related quality issue and FX headwinds, impacting overall profits.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
13.02% Mutual Funds
0.38% Other Institutional Investors
74.94% Public Companies and
Individual Investors
0A0D FAQ
What was Alcon Inc’s price range in the past 12 months?
Alcon Inc lowest share price was CHF61.36 and its highest was CHF85.56 in the past 12 months.
What is Alcon Inc’s market cap?
Currently, no data Available
When is Alcon Inc’s upcoming earnings report date?
Alcon Inc’s upcoming earnings report date is Nov 12, 2024 which is in 33 days.
How were Alcon Inc’s earnings last quarter?
Alcon Inc released its earnings results on Aug 20, 2024. The company reported CHF0.631 earnings per share for the quarter, missing the consensus estimate of CHF0.649 by -CHF0.018.
Is Alcon Inc overvalued?
According to Wall Street analysts Alcon Inc’s price is currently Undervalued.
Does Alcon Inc pay dividends?
Alcon Inc pays a Annually dividend of CHF0.24 which represents an annual dividend yield of 0.28%. See more information on Alcon Inc dividends here
What is Alcon Inc’s EPS estimate?
Alcon Inc’s EPS estimate is CHF0.63.
How many shares outstanding does Alcon Inc have?
Alcon Inc has 499,700,000 shares outstanding.
What happened to Alcon Inc’s price movement after its last earnings report?
Alcon Inc reported an EPS of CHF0.631 in its last earnings report, missing expectations of CHF0.649. Following the earnings report the stock price went down -2.855%.
Which hedge fund is a major shareholder of Alcon Inc?
Among the largest hedge funds holding Alcon Inc’s share is Manning & Napier Advisors LLC. It holds Alcon Inc’s shares valued at 90M.
---
Alcon Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
CHF87.93 (6.97% Upside)
CHF87.93 (6.97% Upside)
Blogger Sentiment
Bullish
GB:0A0D Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.01%
12-Months-Change
Fundamentals
Return on Equity
5.39%
Trailing 12-Months
Asset Growth
1.74%
Trailing 12-Months
Company Description
Alcon Inc
Alcon Inc. is a medical company which is specialized in eye care products. The company develops, manufactures, distributes, and sells technologies and devices for cataract, retinal, refractive surgery, as well as contact lenses and lens care products.
---
0A0D Company Deck
---
0A0D Earnings Call
Q2 2024
0:00 / 0:00
---
0A0D Stock 12 Month Forecast
Average Price Target
CHF87.93
▲(6.97% Upside)
Technical Analysis
Best Analysts Covering 0A0D
1 Year
1 Year Success Rate
10/11 ratings generated profit
1 Year Average Return
+13.25%
reiterated a buy rating 24 days ago
Copying Graham Doyle's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +13.25% per trade.
---